T-E Meds has been selected as a finalist for the Start-up Stadium picking competition in the BIO international convention. T-E Meds stand out through its innovative “Multi-Arm Linker” technology platform. This technology can be utalized to design and create novel ADC/ARC drugs to improve the efficacy and safety. T-E Meds was also selected as an
BIO 2023 International Convention in Boston Read More »
Dr. Hsing-Mao Chu, VP of R&D at Immunwork is speaking at the 2nd Next-Generation Conjugates Summit in Boston next week. Dr. Chu will introduce our innovative antibody-radionuclide conjugate (ARC) technology platform and its application in pancreatic cancer diagnosis/treatment.Join us at this exciting conference!
Immunwork to present at the 2nd Next-Generation Conjugates Summit in Boston Read More »
Immunwork, Inc., today announced that it is presenting at Biotech Showcase™ 2023. This year, registered attendees can view Immunwork’s presentation live, and also access a recorded version. With 24×7 on-demand access, attendees can view recorded presentations at their convenience when scheduling does not allow viewing during the main event week. Dr. Kun-Po Li, Manager of
Reported link: https://www.immunwork.com/include/download.php?dl=MjAyMTAwNDI0X158ZmlsZXNhcHBlbmRzXnwwMDAwMDAwMDAx
【Reported by Economic Daily】Immunwork’s novel drugs challenge incurable diseases Read More »
Reported link: https://news.gbimonthly.com/tw/article/show.php?num=54517&kind=1
Reported link: https://www.immunwork.com/include/download.php?dl=MjAyMTAwNDI0X158ZmlsZXNhcHBlbmRzXnwwMDAwMDAwMDAy
Reported link: https://www.immunwork.com/include/download.php?dl=MjAyMTAwNDI0X158ZmlsZXNhcHBlbmRzXnwwMDAwMDAwMDAz
Reported link: https://news.gbimonthly.com/tw/article/show.php?num=48890
Reported link: https://www.moneyweekly.com.tw/Magazine/Info/%E7%90%86%E8%B2%A1%E5%91%A8%E5%88%8A/78244
